Home › Oropharyngeal Cancer › Vermont
Oropharyngeal Cancer clinical trials in Vermont
3 studies for Oropharyngeal Cancer are looking for participants at sites in Vermont.
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Dartmouth Cancer Center - North, Saint Johnsbury
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05136196Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Dartmouth Cancer Center - North, Saint Johnsbury
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT05451004From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.